Other conditions Board decisions

The VA denied a rating in excess of 40 percent for pelvic fracture residuals, finding that the veteran's condition is currently evaluated at 40 percent.

The veteran's claim for an increased rating for thoracic outlet syndrome was denied by the RO. The case is remanded to obtain additional VA treatment records and determine if a further examination is necessary.

The veteran's claims for increased ratings were denied, and the RO confirmed a noncompensable evaluation for residuals of a laceration of the left ring finger. A noncompensable evaluation was assigned for weakness of the left middle finger and left little finger as secondary to the already service-connected disability involving the left ring finger. The veteran's claim for a 10 percent rating based on multiple, noncompensable service-connected disabilities was also denied.

The Board has determined that the veteran's claims for increased ratings for residuals of fractured mandibles and right heel are not supported by the evidence, as there is no indication of a service-connected condition or exposure basis provided in the decision.

The veteran's chronic chest pain of unknown etiology was first chronically manifested in service after his return from the Southwest Asia Theater of Operations during the Persian Gulf War, and is presumed to be due to an undiagnosed illness.

The VA determined that the veteran's right thumb injury does not meet or approximate the criteria for a higher evaluation, as it does not result in arthritis or inability to move the thumb. The disability is currently rated at 10 percent.

The VA denied the veteran's claim for a higher rating for her lung disorder, finding that her residuals of left thoracotomy and wedge resection for histoplasmosis do not meet the criteria for an evaluation higher than 10 percent.

The Board has denied the appellant's claims for service connection for a skin disorder and genital warts, finding that there is no evidence to support these conditions were incurred during his military service.

The Board denied the veteran's claim for service connection for RA, as secondary to herbicide exposure. The RO previously denied this claim in April 1994 and the veteran appealed.

The VA determined that there is no evidence of active malaria or its residuals, leading to a denial of the claim for an increased rating.

The VA has determined that the veteran's service-connected disabilities do not prevent him from obtaining and maintaining gainful employment.

The Board has granted a 10% evaluation for the veteran's shrapnel wounds of the head and face, effective August 30, 2002.

The Board denied the veteran's claims for effective dates prior to September 21, 2001 for awards of temporary total rating (T/TR) under the provisions of 38 C.F.R. § 4.30 and special monthly compensation (SMC) based on housebound status.

The Board has determined that the veteran's macular degeneration was not incurred in or aggravated by his military service and therefore denied the claim for service connection.

The Board has remanded the case to the RO for a Travel Board hearing due to the veteran's request.

The veteran's appeal is being remanded for additional development, including obtaining updated medical records and scheduling a VA examination to assess the severity of his right brachial plexus injury.

The Board has determined that the appellant is the veteran's surviving spouse for purposes of entitlement to VA improved death pension benefits.

The veteran is seeking to reopen his claim for service connection for residuals of a head injury. The RO has not obtained the SSA records, which may be relevant to his disability benefits application.

The Board has determined that the evidence is at least in equipoise with regard to whether the veteran's current left eye infection and early cataract are related to his service, thus granting service connection for these conditions.

The Board has determined that the evidence is in equipoise, and thus grants service connection for a retinal disorder secondary to antimalarial medication.